EUVIMEDEUVIMED entdecken
Crossref

Biomimetic Cell Membrane‑Coated Nanoparticles for Drug Delivery: Structural Design, Therapeutic Applications, Pharmacokinetics, and Translational Challenges

Pavithra Bharathy, Allen Christopher M, Priya Modhugur Sathyanarayanan, Magesh Mohan, Tharun Devakumar, Ragul Richard Murali

International Journal of Drug Delivery Technology · 01.06.2026 · 16 (42s)

DOI: 10.25258/ijddt.16.42s.10 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 01.06.2026. Verfasst von Pavithra Bharathy und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The newly developed biomimetic cell membrane-coated nanoparticles have already been considered an excellent platform in drug delivery systems that combined the superiorities of the artificial nanomaterials and the natural biological functions of the cell membrane. Due to the fast clearance, poor targeting efficacy and systemic toxicity of many conventional drug delivery systems, the treatment effect was limited. However, the biomimetic cell membrane-coated nanoparticles possessed improved biocompatibility, immune escape property and long circulation time through integrating membrane-associated protein (such as CD47). In this review, the structure architecture, the source of the membrane and fabrication strategies and mechanism theory of biomimetic nanoparticles were provided in detail. Several kinds of cell membrane materials such as red blood cells, cancer cells, platelets and immune cells are discussed for its targeting and application, as well as application of such nanoplatform in numerous kinds of disease, including cancer, infectious diseases, inflammation, cardiovascular and cerebrovascular diseases, nervous system diseases, detoxification, gene delivery and vaccine delivery. In addition, issues of pharmacokinetics, biodistribution, clinical translation and regulation issues, and safety aspects are analysed in depth. Although favourable preclinical performances, challenges regarding scale-up production, quality control, regulation and safety are yet considered a hurdle to clinical application.

Zitieren

APA

Bharathy, P., M, A. C., Sathyanarayanan, P. M., Mohan, M., Devakumar, T., & Murali, R. R. (2026). Biomimetic Cell Membrane‑Coated Nanoparticles for Drug Delivery: Structural Design, Therapeutic Applications, Pharmacokinetics, and Translational Challenges. International Journal of Drug Delivery Technology, 16(42s). https://doi.org/10.25258/ijddt.16.42s.10

Vancouver

Bharathy P, M AC, Sathyanarayanan PM, Mohan M, Devakumar T, Murali RR. Biomimetic Cell Membrane‑Coated Nanoparticles for Drug Delivery: Structural Design, Therapeutic Applications, Pharmacokinetics, and Translational Challenges. International Journal of Drug Delivery Technology. 2026;16(42s). doi:10.25258/ijddt.16.42s.10

BibTeX
@article{Bharathy2026,
  author = {Bharathy, Pavithra and M, Allen Christopher and Sathyanarayanan, Priya Modhugur and Mohan, Magesh and Devakumar, Tharun and Murali, Ragul Richard},
  title = {Biomimetic Cell Membrane‑Coated Nanoparticles for Drug Delivery: Structural Design, Therapeutic Applications, Pharmacokinetics, and Translational Challenges},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {42s},
  doi = {10.25258/ijddt.16.42s.10}
}
Kostenlos starten →